BBC Business & Tech Journalist & Late Editor
Charlotte Edwards is a BBC Business & Tech Journalist and Late Editor. She specializes in finance and trading, covering topics such as algorithmic trading, day trading, forex trading, international trade, and trade laws. Charlotte's insights and expertise have been featured in Citywire, Yahoo News Singapore, and DirectorsTalk Interviews.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Charlotte Edwards primarily covers investment analysis, with a focus on stock market trends and share price targets. Her articles also touch upon consumer technology issues related to products like Amazon Fire TV Stick.
Given her coverage attributes, Charlotte would be receptive to pitches from financial experts who can provide in-depth analysis of stock market trends, offer insights into investment opportunities or discuss data-driven predictions about specific companies' performance.
For the consumer technology topics she has covered, Charlotte may consider pitches offering expert commentary on product usage and optimization tips for popular devices such as Amazon Fire TV Stick.
It's important to note that Charlotte does not have a specified geographic focus and tends to cover global investment trends and consumer technology issues.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Charlotte Edwards
Natera, Inc. with ticker code (NTRA) have now 18 analysts in total covering the stock. The consensus rating is pointing to ‘buy'.
By: Charlotte Edwards
Gilead Sciences, Inc. which can be found using ticker (GILD) now have 26 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy'.
By: Charlotte Edwards
CVS Health Corporation with ticker code (CVS) have now 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy'.
By: Charlotte Edwards
Elevance Health, Inc. with ticker code (ELV) have now 18 analysts in total covering the stock. The consensus rating is pointing to ‘buy'.
By: Charlotte Edwards
Pfizer Inc. which can be found using ticker (PFE) now have 22 analysts in total covering the stock. The consensus rating is pointing to ‘buy'.
By: Charlotte Edwards
Zoetis Inc. with ticker code (ZTS) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy'.
By: Charlotte Edwards
AbbVie Inc. with ticker code (ABBV) now have 25 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy'.
By: Charlotte Edwards
Exelixis, Inc. with ticker code (EXEL) have now 19 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy'.
By: Charlotte Edwards
Amgen Inc. with ticker code (AMGN) now have 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy'.
By: Charlotte Edwards
Doximity, Inc. with ticker code (DOCS) have now 14 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold'.
